The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CGS | +193.33% | +196.37% | +24.27% | +507% |
| S&P | +14.08% | +93.57% | +14.12% | +498% |
Cogstate Ltd. is a global cognitive science company. It delivers software services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company operates through the following segments: Clinical Trials, Healthcare and Academic Research. The Clinical Trials segment provides solutions to optimize clinical outcome assessments to better measure drug efficacy and safety. The Healthcare segment provides tools to detect patient cognitive impairment and change throughout the continuum of care. The Academic Research provides Technology for researchers studying cognition, from academics to public-private partnerships. Cogstate was founded by David Gordon Darby and Paul Maruff on December 17, 1999 and is headquartered in Melbourne, Australia.
No news articles found for Cogstate.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
